Malignant Fallopian Tube Neoplasm — Trials

Malignant Fallopian Tube Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

744 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 168
Recruiting: 76
Ph III recruiting: 12
Growth YoY: +3.8%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 351–357 of 357 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00189566	Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse	completed	Phase 2	165	ARCAGY/ GINECO GROUPOTHER	1	Feb 25, 2011	clinicaltrials
NCT00517621	Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire	completed	Phase 2	100	ARCAGY/ GINECO GROUPOTHER	1	Feb 25, 2011	clinicaltrials